Profile data is unavailable for this security.
About the company
4Sc AG is a Germany-based clinical-stage biopharmaceutical company that develops small-molecule drugs that target key indications in cancer through epigenetic mechanisms. The Company’s product pipeline includes several anti-cancer drugs, which are in various stages of preclinical and clinical development. Its main products are Resminostat, an orally administered histone deacetylase (HDAC) inhibitor for the treatment of a broad spectrum of oncology indications, both in monotherapy in combination with other anti-cancer drugs; 4SC-202, an orally administered small molecule and epigenetic modulator that inhibits the enzymes lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) 1, 2, 3, and 4SC-208, a small molecule that targets two kinases for Hedgehog/GLI signaling.
- Revenue in EUR (TTM)359.00k
- Net income in EUR-7.53m
- Incorporated2000
- Employees15.00
- Location4Sc AGFraunhoferstr. 22PLANEGG 82152GermanyDEU
- Phone+49 897007630
- Fax+49 8 970076329
- Websitehttps://www.4sc.de
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mendus AB (publ) | 0.00 | -12.22m | 41.32m | 28.00 | -- | 0.685 | -- | -- | -3.54 | -3.54 | 0.00 | 13.87 | 0.00 | -- | -- | 0.00 | -21.08 | -18.84 | -23.01 | -20.21 | -- | -- | -- | -28,474.53 | -- | -- | 0.0318 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
| Novacyt SA | 22.27m | -44.83m | 42.80m | 240.00 | -- | 0.5061 | -- | 1.92 | -0.6347 | -0.6396 | 0.3154 | 1.20 | 0.1603 | -3.66 | 1.02 | 82,493.40 | -32.27 | 10.94 | -38.44 | 14.49 | 153.78 | 61.98 | -201.27 | 17.64 | 3.82 | -23.91 | 0.1573 | -- | -44.97 | -0.9408 | -25.22 | -- | 2.09 | -- |
| Mabion SA | 25.47m | 2.35m | 43.84m | 226.00 | 18.62 | 1.47 | 9.95 | 1.72 | 0.6336 | 0.6336 | 6.86 | 8.00 | 0.5407 | 3.12 | 19.98 | 490,238.90 | 5.00 | -7.19 | 7.00 | -16.79 | 78.29 | 58.10 | 9.24 | -14.27 | 1.26 | 18.35 | 0.0281 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
| Alligator Bioscience AB | 2.39m | -21.45m | 44.33m | 47.00 | -- | -- | -- | 18.51 | -0.3667 | -0.3667 | 0.0403 | -0.1001 | 0.201 | -- | 9.80 | 478,017.30 | -180.01 | -73.26 | -2,941.13 | -91.33 | -- | -- | -895.60 | -811.68 | -- | -27.01 | -- | -- | 62.78 | 16.60 | -28.53 | -- | -20.34 | -- |
| Abionyx Pharma SA | 4.86m | -3.36m | 47.16m | 61.00 | -- | 4.60 | -- | 9.71 | -0.1063 | -0.1063 | 0.1548 | 0.2934 | 0.3316 | 21.80 | 6.05 | 80,264.46 | -22.93 | -18.82 | -33.15 | -28.87 | 19.19 | 14.32 | -69.15 | -128.54 | 2.22 | -114.07 | 0.2513 | -- | -11.65 | 92.84 | 16.36 | -- | 41.40 | -- |
| Poolbeg Pharma PLC | 0.00 | -5.25m | 50.40m | 8.00 | -- | 3.37 | -- | -- | -0.0088 | -0.0088 | 0.00 | 0.0249 | 0.00 | -- | -- | 0.00 | -29.11 | -- | -30.18 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 16.11 | -- | -- | -- |
| Poltreg SA | 137.92k | -4.00m | 53.60m | 23.00 | -- | 2.94 | -- | 388.62 | -3.74 | -3.74 | 0.1287 | 17.04 | 0.0051 | 27.12 | 3.22 | 26,373.63 | -14.82 | -6.51 | -16.41 | -7.35 | -1,804.83 | -391.38 | -2,903.50 | -449.24 | 4.21 | -- | 0.0913 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| Promimic AB | 3.53m | -902.37k | 58.02m | 17.00 | -- | 9.47 | -- | 16.42 | -0.563 | -0.563 | 2.21 | 3.80 | 0.4828 | -3.88 | 3.92 | 2,406,824.00 | -12.33 | -24.89 | -14.16 | -29.25 | 104.60 | 101.23 | -25.54 | -89.47 | 4.51 | -- | 0.00 | -- | 128.63 | -- | 41.95 | -- | -- | -- |
| 4Sc AG | 359.00k | -7.53m | 58.02m | 15.00 | -- | 49.09 | -- | 161.62 | -0.7444 | -0.7444 | 0.0355 | 0.1084 | 0.0385 | -- | 3.29 | 23,933.33 | -80.73 | -39.49 | -134.75 | -42.84 | 79.67 | 92.24 | -2,097.22 | -337.74 | -- | -- | 0.00 | -- | -30.28 | -40.78 | 42.64 | -- | -56.05 | -- |
| Intellego Technologies AB | 19.97m | 7.16m | 59.07m | 62.00 | 8.57 | 3.16 | 7.55 | 2.96 | 3.03 | 3.03 | 8.50 | 8.20 | 0.8298 | 4.24 | 2.45 | 3,729,807.00 | 29.74 | -- | 37.90 | -- | 68.61 | -- | 35.83 | -- | 1.88 | 8.84 | 0.1532 | -- | 222.74 | -- | 493.56 | -- | -- | -- |
| Pangaea Oncology SA | 8.00m | -4.66m | 59.19m | 155.00 | -- | 2.91 | -- | 7.40 | -0.1504 | -0.1504 | 0.2631 | 0.5913 | 0.2796 | 8.73 | 1.70 | 51,602.32 | -16.76 | -13.74 | -20.78 | -17.34 | 48.22 | 67.27 | -59.93 | -60.67 | 1.27 | -42.93 | 0.1535 | -- | 83.12 | 21.20 | -71.69 | -- | 60.52 | -- |
| Nykode Therapeutics ASA | 5.78m | -35.64m | 59.41m | 179.00 | -- | 0.4156 | -- | 10.28 | -1.34 | -1.34 | 0.2125 | 5.15 | 0.0333 | -- | 1.59 | 392,793.30 | -20.57 | 5.65 | -23.15 | 6.38 | -- | -- | -616.79 | 18.13 | -- | -- | 0.0305 | -- | 79.99 | 282.17 | 17.75 | -- | 187.37 | -- |
| Arcticzymes Technologies ASA | 9.20m | 595.43k | 60.45m | 68.00 | 101.84 | 2.23 | 54.73 | 6.57 | 0.1367 | 0.1367 | 2.10 | 6.24 | 0.3199 | 0.45 | 1.93 | 1,591,059.00 | 2.07 | 15.58 | 2.19 | 17.22 | 93.99 | 96.69 | 6.47 | 33.23 | 14.95 | -- | 0.0273 | 0.00 | -13.16 | 12.24 | -40.89 | -- | 47.93 | -- |
| BIOTON SA | 42.83m | -1.57m | 61.87m | 358.00 | -- | 0.4497 | 10.44 | 1.44 | -0.0797 | -0.0797 | 2.17 | 6.97 | 0.2303 | 1.02 | 21.19 | 520,435.80 | -0.8464 | -1.99 | -1.04 | -2.47 | 33.80 | 45.33 | -3.67 | -8.61 | 0.2085 | 0.3295 | 0.0864 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Captor Therapeutics SA | 4.28m | -10.73m | 63.88m | 104.00 | -- | 5.48 | -- | 14.91 | -10.29 | -10.29 | 4.08 | 10.87 | 0.2391 | -- | 5.26 | 179,230.80 | -59.88 | -- | -83.65 | -- | 51.97 | -- | -250.46 | -- | -- | -- | 0.1114 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
Data as of Nov 13 2024. Currency figures normalised to 4Sc AG's reporting currency: Euro EUR
